Transaction details
On February 20, 2026, Adam David Sachs, president of Vicarious Surgical Inc. (NASDAQ: RBOT), sold 942 shares of the company's Class A common stock for a total of $1,966. The shares changed hands at a weighted average price of $2.0878, with individual transaction prices reported between $1.845 and $2.290. Company filings indicate the disposition was executed to satisfy tax withholding obligations associated with the vesting of restricted stock units, in accordance with Vicarious Surgical Inc.'s equity incentive plan.
Ownership and market context
After the sale, Sachs still directly owns 46,943 shares of Vicarious Surgical. At the time the transaction was reported, the stock was trading at $2.01. The share price has shown significant short-term movement - gaining 22% over the prior week - while remaining down 84% over the preceding year, underscoring pronounced volatility in the company's market value.
Corporate developments
Separately, Vicarious Surgical announced a strategic collaboration with a global digital engineering and software development services firm. Under the agreement, the partner will assume sizable software development responsibilities that the company had previously handled internally, including work on control systems and visualization. The arrangement is presented as part of the company’s efforts to reshape its operating model.
Financial outlook and operational reset
Vicarious Surgical also revised its projected cash burn for 2025, lowering the figure to approximately $45 million from an earlier estimate of $50 million. Company statements attribute the $5 million reduction to disciplined cost management measures implemented as part of an ongoing operational reset. Management has indicated it will provide guidance for the company’s expected cash burn in 2026 before the end of this year.
Valuation note
According to InvestingPro, the company appears undervalued at current levels, with a more detailed analysis available in a Pro Research Report.
Summary of facts
- Adam David Sachs sold 942 Class A shares on February 20, 2026, totaling $1,966.
- Sale executed at a weighted average price of $2.0878; individual prices ranged $1.845 to $2.290.
- Transaction was made to cover tax withholding for vested restricted stock units under the company equity incentive plan.
- After the sale, Sachs owns 46,943 shares directly.
- Vicarious Surgical stock traded at $2.01, up 22% over the prior week and down 84% year over year.
- The company announced a strategic outsourcing partnership for software development and lowered its 2025 cash burn guidance to about $45 million from $50 million.